The Netherlands Cancer Institute (Stichting Het Nederlands Kanker Instituut – Antoni Van Leeuwenhoek Ziekenhuis, NKI AVL) based in Amsterdam, the Netherlands, is a leading European comprehensive cancer centre known for cutting-edge biology, genetics, immunotherapy, and personalized medicine, with a particular focus on the long-term effects of cancer treatments, including reproductive and cardiac health. Within NKI AVL, the research group on personalised oncology in adolescents and young adult patients contributes to realising the objectives of PredictAYA.
NKI AVL leads communication, dissemination and stakeholder engagement activities under WP7 to amplify PredictAYA’s objectives and results to a wide range of European stakeholders. NKI AVL further supports the epidemiological research conducted in WP2.
Olga Husson
Prof
Associate Group Leader
Simone Hanebaum
PhD
Senior Project Manager
Jack Morgan
PhD
Postdoctoral Researcher
Maike Hentges
Research Assistant
